Detection of naturally acquired, strain-transcending antibodies against rosetting Plasmodium falciparum strains in humans
- PMID: 38842304
- PMCID: PMC11238554
- DOI: 10.1128/iai.00015-24
Detection of naturally acquired, strain-transcending antibodies against rosetting Plasmodium falciparum strains in humans
Abstract
Strain-transcending antibodies against virulence-associated subsets of P. falciparum-infected erythrocyte surface antigens could protect children from severe malaria. However, the evidence supporting the existence of such antibodies is incomplete and inconsistent. One subset of surface antigens associated with severe malaria, rosette-mediating Plasmodium falciparum Erythrocyte Membrane Protein one (PfEMP1) variants, cause infected erythrocytes to bind to uninfected erythrocytes to form clusters of cells (rosettes) that contribute to microvascular obstruction and pathology. Here, we tested plasma from 80 individuals living in malaria-endemic regions for IgG recognition of the surface of four P. falciparum rosetting strains using flow cytometry. Broadly reactive plasma samples were then used in antibody elution experiments in which intact IgG was eluted from the surface of infected erythrocytes and transferred to heterologous rosetting strains to look for strain-transcending antibodies. We found that seroprevalence (percentage of positive plasma samples) against allopatric rosetting strains was high in adults (63%-93%) but lower in children (13%-48%). Strain-transcending antibodies were present in nine out of eleven eluted antibody experiments, with six of these recognizing multiple heterologous rosetting parasite strains. One eluate had rosette-disrupting activity against heterologous strains, suggesting PfEMP1 as the likely target of the strain-transcending antibodies. Naturally acquired strain-transcending antibodies to rosetting P. falciparum strains in humans have not been directly demonstrated previously. Their existence suggests that such antibodies could play a role in clinical protection and raises the possibility that conserved epitopes recognized by strain-transcending antibodies could be targeted therapeutically by monoclonal antibodies or vaccines.
Keywords: PfEMP1; antibodies; epitopes; immunology; rosette formation; severe malaria; virulence.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
The humoral response to Plasmodium falciparum VarO rosetting variant and its association with protection against malaria in Beninese children.Malar J. 2010 Oct 5;9:267. doi: 10.1186/1475-2875-9-267. Malar J. 2010. PMID: 20923548 Free PMC article.
-
Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites.PLoS Pathog. 2012;8(4):e1002665. doi: 10.1371/journal.ppat.1002665. Epub 2012 Apr 19. PLoS Pathog. 2012. PMID: 22532802 Free PMC article. Clinical Trial.
-
Immunogenicity of the Plasmodium falciparum PfEMP1-VarO Adhesin: Induction of Surface-Reactive and Rosette-Disrupting Antibodies to VarO Infected Erythrocytes.PLoS One. 2015 Jul 29;10(7):e0134292. doi: 10.1371/journal.pone.0134292. eCollection 2015. PLoS One. 2015. PMID: 26222304 Free PMC article.
-
Three Is a Crowd - New Insights into Rosetting in Plasmodium falciparum.Trends Parasitol. 2017 Apr;33(4):309-320. doi: 10.1016/j.pt.2016.12.012. Epub 2017 Jan 18. Trends Parasitol. 2017. PMID: 28109696 Review.
-
Molecular mechanisms and biological importance of Plasmodium falciparum erythrocyte rosetting.Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:323-9. doi: 10.1590/s0074-02761992000700054. Mem Inst Oswaldo Cruz. 1992. PMID: 1285315 Review.
Cited by
-
Identification of novel PfEMP1 variants containing domain cassettes 11, 15 and 8 that mediate the Plasmodium falciparum virulence-associated rosetting phenotype.PLoS Pathog. 2025 Jan 13;21(1):e1012434. doi: 10.1371/journal.ppat.1012434. eCollection 2025 Jan. PLoS Pathog. 2025. PMID: 39804943 Free PMC article.
-
Plasmodium falciparum infection induces T cell tolerance that is associated with decreased disease severity upon re-infection.J Exp Med. 2025 Jul 7;222(7):e20241667. doi: 10.1084/jem.20241667. Epub 2025 Apr 11. J Exp Med. 2025. PMID: 40214640 Free PMC article.
References
-
- Vigan-Womas I, Guillotte M, Le Scanf C, Igonet S, Petres S, Juillerat A, Badaut C, Nato F, Schneider A, Lavergne A, Contamin H, Tall A, Baril L, Bentley GA, Mercereau-Puijalon O. 2008. An in vivo and in vitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotype. Infect Immun 76:5565–5580. doi:10.1128/IAI.00901-08 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources